Patent ID: 8728473
Filing Date: 2014-05-20
Classification: A61K,A61P,C07K,Y02A

Abstract:
1. A method of treating pain or eliciting an analgesic effect in an individual, comprising administering an effective amount of at least one anti-human NGF antibody or antigen-binding fragment thereof, wherein the anti-NGF antibody comprises the light chain complementarity determining region (CDR)1 of SEQ ID NO:145, the light chain CDR2 of SEQ ID NO:146, the light chain CDR3 of SEQ ID NO:147 or SEQ ID NO:27, the heavy chain CDR1 of SEQ ID NO:148 or SEQ ID NO:28, the heavy chain CDR2 of SEQ ID NO:149 or SEQ ID NO:29, and the heavy chain CDR3 of SEQ ID NO:150 or SEQ ID NO:30 or an antibody or antibody fragment that competes with any of the foregoing antibodies for binding to NGF.